Quinoline derivatives as antagonists of leukotriene D.sub.4
申请人:Rhone-Poulenc Rorer Pharmaceuticals Inc.
公开号:US05051427A1
公开(公告)日:1991-09-24
This invention relates to certain quinoline-diaryl compounds and their use as leukotriene D.sub.4 antagonists for the treatment of hypersensitive disorders.